Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Thyroid Neoplasms 5Thyroid Carcinoma, Anaplastic 4Neuroendocrine Tumors 4Thyroid Cancer, Papillary 3Carcinoma, Medullary 3Adenocarcinoma, Follicular 2Wilms Tumor 1Vipoma 1Thyroid cancer, medullary 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Somatostatinoma 1Neoplastic Cells, Circulating 1Multiple Endocrine Neoplasia Type 2b 1Multiple Endocrine Neoplasia Type 2a 1Insulinoma 1Glucagonoma 1Gastrinoma 1Familial medullary thyroid carcinoma 1Differentiated Thyroid Cancer 1Carcinoma, Islet Cell 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Adrenocortical Carcinoma 1Adenoma, Islet Cell 1

Interventions

lanreotide 1Sorafenib 1Radiofrequency Ablation 1Octreotide 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Sorafenib × Endocrine × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡